eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized


Advanced tools       Explore eHealthMe

From FDA reports: drug interactions between Mysoline, Lamictal, Topamax, Depakene for a Female patient aged 31

This is a personalized study for a 31 year old female patient. The study is created by eHealthMe based on reports of 3 people who take the same drugs and have drug interactionsfrom FDA.

On Aug, 27, 2014: 3 people who reported to have interactions when taking Mysoline, Lamictal, Topamax, Depakene are studied

Trend of Mysoline, Lamictal, Topamax, Depakene's drug interactions, side effects, and effectiveness reports (2857341)

Information of the patient in this study:

Age: 31

Gender: female

Conditions: Lennox-gastaut Syndrome

Drugs taking:
- Mysoline
- Lamictal
- Topamax
- Depakene

Drug interactions have: Drug Interaction, Status Epilepticus

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 31 (±5):

InteractionNumber of reports
Drug Interaction2 (100.00%)
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)2 (100.00%)

Most common interactions experienced by females aged 31 (±5) in the use of Mysoline, Lamictal, Topamax, Depakene:

InteractionNumber of reports
Drug Interaction2
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)2

Most common interactions experienced by females aged 31 (±5) in long term use of Mysoline, Lamictal, Topamax, Depakene:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Drug Interaction3 (100.00%)
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)3 (100.00%)

Most common interactions experienced by people in the use of Mysoline, Lamictal, Topamax, Depakene:

InteractionNumber of reports
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)3
Drug Interaction3
Gait Disturbance3
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)3
Drug Ineffective3
Dizziness3

Most common interactions experienced by people in long term use of Mysoline, Lamictal, Topamax, Depakene:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.